This inventor holds 1 USPTO granted patent. Top assignee: Prism Biolab Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hajime Takashima: Inventor in Kanagawa, Japan.
Introduction
Hajime Takashima is an inventor associated with Prism Biolab Corporation in Kanagawa, Japan. His patent work includes a heterocyclic compound described as having superior inhibitory activity on cancer cell proliferation.
Latest Patents
Takashima is credited with 1 patent: “Heterocyclic compounds.” The patent describes a compound of formula (I), with its symbols defined in the description, or a pharmaceutically acceptable salt thereof. The disclosed compounds are characterized by their inhibitory activity on cancer cell proliferation.
Career Highlights
Takashima’s listed patent reflects work on compounds with potential relevance to cancer research. The available information identifies Prism Biolab Corporation as his company.
Collaborations
His listed coworkers include Eiji Honda and Tomonori Taguri.
Conclusion
Hajime Takashima’s recorded invention focuses on heterocyclic compounds with cancer cell proliferation-inhibitory activity, and his patent work is associated with Prism Biolab Corporation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile